Estados Unidos · Bolsa y Finanzas · Yahoo Finance

Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European market

Publicado por Yahoo Finance · Estados Unidos hace 10 h

ORION CORPORATION PRESS RELEASE 6 OCTOBER 2026 at 9.00 EEST Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European market Orion…

Leer el artículo completo en Yahoo Finance Inicie sesión para guardar

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (finance.yahoo.com)

Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European market

También te puede interesar

I'm the CEO of Zocdoc. Here's how long showers help me manage hectic days.

Euro Area retail sales rise 0.8% Y/Y, below estimates

Battle Between Disney and the F.C.C. Moves to the Courts

OKX Money lets users save, earn 10% yield and spend dollar stablecoins in one app

These are the 10 U.S. cities with the most homes at risk of hurricane damage

Yemen forces reclaim key Red Sea port city from Iran-backed Houthis in major counteroffensive

Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European market

Compartir

También te puede interesar

I'm the CEO of Zocdoc. Here's how long showers help me manage hectic days.

Euro Area retail sales rise 0.8% Y/Y, below estimates

Battle Between Disney and the F.C.C. Moves to the Courts

OKX Money lets users save, earn 10% yield and spend dollar stablecoins in one app

These are the 10 U.S. cities with the most homes at risk of hurricane damage

Yemen forces reclaim key Red Sea port city from Iran-backed Houthis in major counteroffensive